SEOUL: The Samsung group plans to raise spending by more than 30% to 450 trillion won (US$360bil or RM1.58 trillion) over the half-decade to 2026 to shore up businesses from chips to drugs, as South Korea’s conglomerates grapple with growing economic and supply shocks.
The corporate giant – whose units from Samsung Electronics Co to Samsung Biologics Co dominate South Korea’s economy – promised in a statement to create 80,000 jobs through 2026, mostly in semiconductors and biopharmaceuticals.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!